For Clinics

B2B resources and operational guidance for ketamine and psychedelic clinic owners.

Three Psychedelic Companies Analysts Say Could Be Acquired Next

The Deal That Changed the Temperature Eli Lilly agreed in July to pay up to $3.8 billion for AtaiBeckley. That

Read More

How We Saved One Ketamine Clinic Network $38,000 a Year on Medical Supplies

We just negotiated GPO-level medical supply pricing exclusively for Healing Health Alliance members. The proof: one HHA member ketamine practice

Read More

Three Infusions in Twelve Weeks: A Toronto Pain Trial Ran a Very Different Protocol

A Toronto trial paired ketamine with structured therapy for chronic nerve pain. It used three infusions over twelve weeks, not

Read More

FDA Finalizes Psychedelic Trial Guidance, Then Opens A Bigger Federal Conversation

The FDA finalized its first formal guidance for studying psychedelic drugs. The document sets the ground rules for research into

Read More

The Money Behind the MDMA Resubmission Came From a SpaceX Director

The WSJ reported that a SpaceX director gave $25 million to recapitalize the company behind MDMA-assisted therapy. That explains a

Read More

Explore Psychedelic Therapy Regions